Clinical utility of comprehensive circulating tumor DNA genotyping compared with standard of care tissue testing in patients with newly diagnosed metastatic colorectal cancer

Autor: Benavides, M., Alcaide-Garcia, J., Torres, E., Gil-Calle, S., Sevilla, I., Wolman, R., Durán, G., Álvarez, M., Reyna-Fortes, C., Ales, I., Pereda, T., Robles, M., Kushnir, M., Odegaard, J., Faull, I., Alba, E.

Publikováno v: In ESMO Open June 2022 7(3)

6P Circulating tumor DNA (ctDNA) next generation sequencing (NGS): Molecular prescreening for tailoring treatment in clinical trials

Autor: Alonso, G., Aguilar, S., Ros Montana, F.J., Verdaguer, H., Callejo Perez, A., Brana, I., Baraibar Argota, I., Iranzo Gomez, P., Saavedra Santa Gadea, O., Salva Ballabrera, F., Acosta Eyzaguirre, D.A., Vieito Villar, M., Garcia Torralba, E., Wornham, N.A., Faull, I., Tabernero, J., Felip, E., Elez, E., Macarulla Mercade, T., Garralda, E.

Publikováno v: In Annals of Oncology October 2021 32 Supplement 6:S1346-S1348

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD1402 Trial

Autor: Vidal, J, Casadevall, D, Bellosillo, B, Pericay, C, Garcia-Carbonero, R, Losa, F, Layos, L, Alonso, V, Capdevila, J, Gallego, J, Vera, R, Salud, A, Martin-Richard, M, Nogue, M, Cillan, E, Maurel, J, Faull, I, Raymond, V, Fernandez-Martos, C, Montagut, C

Publikováno v: CLINICAL CANCER RESEARCH
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

Purpose: Total neoadjuvant treatment (TNT) is a valid strategy for patients with high-risk locally advanced rectal cancer (LARC). Biomarkers of response to TNT are an unmet clinical need. We aimed to determine the value of circulating tumor DNA(ctDNA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6b6059bee9ac1b59d02af28bd8b487d9
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=11783

Circulating tumor DNA dynamics using a standardized multi-gene panel in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy

Autor: Barbara Adamo, Blanca Gonzalez-Farre, F. Salvador, Montserrat Muñoz, Benedetta Conte, Esther Sanfeliu, Adela Rodriguez, Olga Martínez-Sáez, T. Pascual, Faull I, Fara Brasó-Maristany, Martinez A, Maria Vidal, Belén Rodríguez A, D. Martinez, Patricia Galván, Patricia Villagrasa, Francesco Schettini, Reinaldo Moreno, Eva Ciruelos, Nuria Chic, Odegaard Ji, Aleix Prat

Brief communicationCirculating tumor DNA (ctDNA) levels may predict response to anticancer drugs1, including CDK4/6 inhibitors and endocrine therapy combinations (CDK4/6i+ET)2; however, critical questions remain unanswered such as which assay or stat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac9b6e801fd27fc49ece2654156280ee
https://doi.org/10.1101/2020.06.29.20142257

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.